Inventor
HERMANN AYNUR
US11 patents
Patents
11 patentsUS10358495B2Jul 23, 2019
Anti-LAG3 antibodies and uses thereof
REGENERON PHARMA47 citations96
US11548947B2Jan 10, 2023
Bispecific anti-PSMA X anti-CD28 antibodies and uses thereof
REGENERON PHARMA10 citations84
US11453721B2Sep 27, 2022
Bispecific anti-MUC16 x anti-CD28 antibodies and uses thereof
REGENERON PHARMA10 citations84
US11396544B2Jul 26, 2022
Bispecific anti-CD28 × anti-CD22 antibodies and uses thereof
REGENERON PHARMA8 citations83
US11905332B2Feb 20, 2024
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
REGENERON PHARMA3 citations72
US11692032B2Jul 4, 2023
Anti-LAG3 antibodies and uses thereof
REGENERON PHARMA3 citations72
US10844137B2Nov 24, 2020
Anti-CTLA-4 antibodies and uses thereof
REGENERON PHARMA2 citations72
US12024570B2Jul 2, 2024
Anti-CTLA-4 antibodies and uses thereof
REGENERON PHARMA0 citations62
US12441800B2Oct 14, 2025
Bispecific anti-PSMA x anti-CD28 antibodies and uses thereof
REGENERON PHARMA0 citations61
US12590168B2Mar 31, 2026
Antigen-binding molecules that bind CD38 and/or CD28, and uses thereof
REGENERON PHARMA0 citations60
US12559576B2Feb 24, 2026
CD20-PD1 binding molecules and methods of use thereof
REGENERON PHARMA0 citations59